Techne Corp (NASDAQ:TECH)

CAPS Rating: 5 out of 5

The Company and its subsidiaries are engaged in the development and manufacture of biotechnology products and hematology calibrators and controls.

Recs

0
Player Avatar cashkid79 (93.43) Submitted: 2/23/2010 8:07:33 PM : Outperform Start Price: $60.79 TECH Score: -6.28

I like R&D in biotech. This is great exposure to the sector. Research/Development (and global presence) = Innovations/Patents/Profits - it just makes sense...LONG

Featured Broker Partners


Advertisement